Source:http://linkedlifedata.com/resource/pubmed/id/18489503
Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
7
|
| pubmed:dateCreated |
2009-7-15
|
| pubmed:abstractText |
To examine the short-term impact of quadrivalent human papillomavirus (HPV) (types 6/11/16/18) recombinant vaccination upon HPV disease-related health-care resource utilization and costs among young women.
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:month |
Dec
|
| pubmed:issn |
1524-4733
|
| pubmed:author | |
| pubmed:issnType |
Electronic
|
| pubmed:volume |
11
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
1022-32
|
| pubmed:meshHeading |
pubmed-meshheading:18489503-Adolescent,
pubmed-meshheading:18489503-Costs and Cost Analysis,
pubmed-meshheading:18489503-Female,
pubmed-meshheading:18489503-Follow-Up Studies,
pubmed-meshheading:18489503-Health Care Costs,
pubmed-meshheading:18489503-Humans,
pubmed-meshheading:18489503-Papillomavirus Infections,
pubmed-meshheading:18489503-Papillomavirus Vaccines,
pubmed-meshheading:18489503-Young Adult
|
| pubmed:year |
2008
|
| pubmed:articleTitle |
Reductions in human papillomavirus-disease resource use and costs with quadrivalent human papillomavirus (types 6, 11, 16, and 18) recombinant vaccination: the FUTURE Study Economic Evaluation.
|
| pubmed:affiliation |
Department of Health Economics Statistics, Merck Research Laboratories, North Wales, PA 19454-1099, USA. ralph_insinga@merck.com
|
| pubmed:publicationType |
Journal Article,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|